Although oncogenic activation of tumour metabolism renders cancer cells probably liable to inhibition of various metabolic pathways, these pathways can also be employed by immune cells25, specifically on receptor stimulation, for instance T mobile receptor (TCR) engagement together with CD28 activation. On this regard, specific inhibition of specif